Effect of tesaglitazar, a dual PPAR alpha/gamma agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial (Q51483374)
scientific article published in December 2006
Language:
(P31) (Q13442814)
(P50) (Q60996888)
(P304) 2575-2590
(P407) (Q1860)
(P433) 12
(P478) 22
(P577) Friday, December 1, 2006
(P921) (Q3025883)
(P1433) (Q5195063)
(P1476) "Effect of tesaglitazar, a dual PPAR alpha/gamma agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial" (language: en)
(P2093) Barry J Goldstein
Deborah Anzalone
Conrad Tou
K Peter Ohman
other details
description scientific article published in December 2006

External Links